WADA makes deal with Pfizer to help combat doping

Pfizer will review substances under development to see if they share similarities with PEDs

Multi-national pharmaceutical corporation Pfizer signed a deal with the World Anti-Doping Agency (WADA) on Wednesday, to help identify substances that could pose a high risk of potentially being used as a performance enhancing drug (PED) by athletes.

The agreement will see Pfizer review substances under development to see how they work in the human body and if they share similarities to any drugs previously used as PEDs.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1